XEME Biopharma Inc. Email Format
Biotechnology ResearchNew Jersey, United States2-10 Employees
XEME Biopharma Inc. is a clinical-stage biotechnology company focused on developing vaccines for active cancer immunotherapy, aiming to shift cancer treatment beyond traditional options such as surgery, radiation, chemotherapy, and passive immunotherapy. The firm is based in Monmouth Junction, New Jersey, and operates with a small team. Its work centers on personalized autologous vaccines intended for leukemia and lymphoma.